What is DocGo Inc (DCGO) stock price today?

DocGo Inc (DCGO) currently trades at $0.71 per share. The stock has a market capitalization of $70.92M and a P/E ratio of —x.

Is DCGO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, DocGo Inc has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 1.88.

What is DocGo Inc's revenue and earnings?

DocGo Inc has trailing twelve-month (TTM) revenue of $322.20M with profit margins of -56.60%. Earnings per share (EPS) is $-1.84.

Is DocGo Inc financially healthy?

DocGo Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 1.88 places it in the grey zone.

DCGO

DocGo Inc

NASDAQ: DCGO · HEALTHCARE · MEDICAL CARE FACILITIES

$0.71

-0.20% today

Updated 2026-04-30

Market cap

$70.92M

P/E ratio

—

P/S ratio

0.22x

EPS (TTM)

$-1.84

Dividend yield

—

52W range

$0 – $2

Volume

1.1M

Market cap

$70.92M

P/E ratio

—

P/S ratio

0.22x

EPS (TTM)

$-1.84

Dividend yield

—

52W range

$0 – $2

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

3.3

Growth

7.0

Quality

B+

2.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

1.9

Altman Z-Score

Grey zone

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$2.10

+197.58%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.11x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at -56.60%

- Negative free cash flow $-12.60M

- Revenue declining -38.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$440.52M	$624.29M	$616.56M	$322.20M	$322.20M
Net income	$34.58M	$6.86M	$19.99M	$-182.40M	$-134.07M
EPS	—	—	—	—	$-1.84
Free cash flow	$23.37M	$-74.35M	$64.50M	$27.02M	$-12.60M
Profit margin	7.85%	1.10%	3.24%	-56.61%	-56.60%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DCGO	$70.92M	36	3.3	2.0	5.0	7.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

DocGo Inc trades at $0.71. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 1.88, it sits in the grey zone. TTM revenue stands at $322.20M. with profit margins at -56.60%.

Frequently asked questions

What is DocGo Inc's stock price?

DocGo Inc (DCGO) trades at $0.71.

Is DocGo Inc overvalued?

Smart Value Score 36/100 (Grade D, Sell).

What is the price target of DocGo Inc (DCGO)?

The analyst target price is $2.10, representing +197.6% upside from the current price of $0.71.

What is DocGo Inc's revenue?

TTM revenue is $322.20M.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

1.88 — grey zone.

Company info

SectorHEALTHCARE

IndustryMEDICAL CARE FACILITIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.docgo.com

Quick metrics

P/S ratio0.22x

ROE-89.00%

Beta0.98

50D MA$0.66

200D MA$1.06

Shares out0.10B

Float0.10B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DCGO vs LLY →DCGO vs JNJ →DCGO vs ABBV →Stock screener →